First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
Source: benzinga.com
Beckley Psytech Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Beckley Psytech Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Beckley Psytech Ltd Today - Breaking & Trending Today
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)
Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury
Source: benzinga.com
Investment To Reinforce Atai's 'Largest And Most Diverse' Clinical-Stage Psychedelics Portfolio In The Sector - GH Research (NASDAQ:GHRS), ATAI Life Sciences (NASDAQ:ATAI)
Biopharma and resources-pooling company Atai Life Sciences (NASDAQ: ATAI) has invested a total of $50 million in Beckley Psytech Ltd., a U.K.-based clinical-stage biotech advancing short-duration psychedelics for neuropsychiatric conditions.
Source: benzinga.com
Atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
Strategic investment in Beckley Psytech reinforces atai’s position as the biopharmaceutical company with the largest and most diverse portfolio of clinical-stage psychedelic candidatesTwo...
Source: marketscreener.com
Cedar Clinical Research selected as clinical research site for Beckley Psytech's Phase 2b Study
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...
Source: prnewswire.com